Sanat Chattopadhyay Merck & Co., Inc.

Sanat Chattopadhyay is Executive Vice President and President of Merck’s Manufacturing Division with responsibility for the company’s (2024 revenue: $64.2 billion) worldwide manufacturing and supply operations across a global network of sites for pharmaceuticals, vaccines, biologics and animal health products. A proven leader in the biopharmaceutical industry, Sanat joined Merck in November 2009 as Senior Vice President of Global Vaccines & Sterile Manufacturing Operations, spearheading the transformation of manufacturing and supply chain to grow and globalize its Vaccine business. He also played a key role in leading the company's launch of KEYTRUDA® (pembrolizumab) in record time by mobilizing a cross-divisional effort to overcome commercialization and supply constraints. Under Sanat’s leadership, Merck is currently executing a significant expansion of its biologics and vaccines manufacturing capacity with planned capital investments of more than $20 billion from 2020 through the end of 2024, to reach more patients around the globe. Before joining Merck, he served as Senior Vice President, Technical Operations & Product Supply, for Wyeth Pharmaceuticals, with responsibility for product supply, process development and operational excellence. Previously, he worked at Aventis and its predecessor companies as Senior Vice President, Industrial Operations, having served in many positions with increasing responsibilities for global supply chain, technology and manufacturing sites across North America, Europe and Asia Pacific. Outside of Merck, Sanat is a member of the Advisory Board of USA-India Chamber of Commerce focused on creating an ecosystem committed to driving a global dialogue on BioPharma & Healthcare Innovation and enabling mutually beneficial opportunities and relationships for the global Life Sciences & Healthcare Industry. Additionally, Sanat is on the Board of Directors of the US-India Strategic Partnership Forum (USISPF) the only independent not-for-profit institution dedicated to strengthening the U.S.-India partnership in Washington, D.C. and in New Delhi. USISPF is the trusted partner for businesses, non-profit organizations, the diaspora, and the governments of India and the United States. He is a member of the Board of Directors at Ashland, a global additives and specialty ingredients company dedicated to responsibly solving complex problems for customers in various industries.